AstraZeneca Pharma India Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	1,875	1,157	1,615	992.9	616
Depreciation & Amortization	285.8	385.4	148.1	162.6	169.5
Other Amortization	-	14.5	1.3	-	-
Loss (Gain) From Sale of Assets	-1.6	-3.2	-0.3	-24.9	-28.2
Asset Writedown & Restructuring Costs	55.4	4.6	12.4	-	-
Stock-Based Compensation	10.9	51.4	27.4	23.7	18.2
Provision & Write-off of Bad Debts	179.9	6.6	54.4	17	42.9
Other Operating Activities	-383.2	69.1	-298	-286.5	-139.3
Change in Accounts Receivable	-458.1	-316.8	-511.8	-231.7	-49
Change in Inventory	-4,788	-3,206	-376.7	-499.9	195.8
Change in Accounts Payable	3,264	2,598	-313.7	374.4	120.5
Change in Other Net Operating Assets	-191.4	-107.3	-79.5	55.3	61.6
Operating Cash Flow	-151.4	653.6	278.7	582.9	1,008
Operating Cash Flow Growth	-	134.52%	-52.19%	-42.17%	-3.80%
Capital Expenditures	-15.6	-17.5	-107.6	-85.2	-96.2
Sale of Property, Plant & Equipment	2.7	7.1	4.1	34.8	32.5
Other Investing Activities	199.8	318.4	320.9	231.5	111.1
Investing Cash Flow	186.9	308	217.4	181.1	47.4
Long-Term Debt Repaid	-74.8	-41.3	-38.6	-38.5	-35.1
Total Debt Repaid	-74.8	-41.3	-38.6	-38.5	-35.1
Net Debt Issued (Repaid)	-74.8	-41.3	-38.6	-38.5	-35.1
Common Dividends Paid	-800	-600	-400	-200	-50
Other Financing Activities	-44.9	-14.6	-5.2	-6.3	-9.5
Financing Cash Flow	-919.7	-655.9	-443.8	-244.8	-94.6
Net Cash Flow	-884.2	305.7	52.3	519.2	960.8
Free Cash Flow	-167	636.1	171.1	497.7	911.8
Free Cash Flow Growth	-	271.77%	-65.62%	-45.42%	-6.07%
Free Cash Flow Margin	-0.73%	3.71%	1.32%	4.96%	11.32%
Free Cash Flow Per Share	-6.68	25.44	6.84	19.91	36.47
Cash Interest Paid	-	14.6	5.2	6.3	9.5
Cash Income Tax Paid	-	641.9	564.3	408.2	247.9
Levered Free Cash Flow	-259.94	1,391	-37.96	762.44	901.26
Unlevered Free Cash Flow	-231.88	1,400	-30.46	766.38	907.2
Change in Working Capital	-2,174	-1,032	-1,282	-301.9	328.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.